Thousands of CALIFORNIA REALTORS® will gather next week for the state's premier real estate trade show at the Long Beach Convention Center in Long Beach Calif. REimagine! Conference & Expo,...

Innovative safety solutions can come in many forms, ranging from head protection that features the latest technology to help protect against lateral impacts to connected technology that alerts...

-- Presentation will Feature the Fully Integrated Aspects of EDETEK's Services Within the CONFORM™ Platform, Ensuring Flawlessly Orchestrated Biometric Data Management -- PRINCETON, N.J., Sept....

Strongest Possible Security and Privacy Protections Afforded to Medical Data, Enabling Healthcare Organizations to Take Advantage of Leading Parcel Spend Management Platform With Confidence...

In this free webinar, learn how AI can be applied to streamline clinical care, improve treatment outcomes and prove the value of healthcare services to stakeholders. Attendees will learn how to...

– TiNivo-2 results published in The Lancet – – TiNivo-2 FOTIVDA® (tivozanib) monotherapy (control arm) results provide clinically meaningful efficacy and safety data following front-line...

Longtime financial literacy advocate joins CBC Chairman Rep. Steven Horsford, Ariel Investments Co-CEO John Rogers, Fearless Fund founder Arian Simone, and Don Lemon for a National Town Hall, in...

Hesai Technology (Nasdaq: HSAI), the global leader in lidar technology, is launching its powerful new lidar solution OT128 at Europe's biggest commercial vehicle trade fair IAA Transportation in...

World Business Chicago hosts a week-long event from September 23-27 to connect fintech and insurtech startups with essential resources, networks, and top investors. CHICAGO, Sept. 16, 2024...

The UAE BioTech Symposium will attract U.S. and international BioTech owners and executives new to exploring opportunities in the UAE market Secondcell Bio CEO Dr. Kambiz Shekdar will serve as...

Neptune and ASUG Partner To Help Audiences Unlock Full Potential of SAP Investments OSLO, Norway, Sept. 16, 2024 /PRNewswire/ -- Leading low-code, SAP-centric app development platform vendor...

Full suite of state-of-the-art packs for a broad range of electric vehicles and machinery. Purpose-built, custom battery packs that enable superior electric vehicles for precise client needs....

In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an...

MEDSIR together with Oncoclinicas & Co., leads independent clinical research at the largest European congress of medical oncology, with the presentation of 12 studies, marking a new scientific...

Aerospace Technical Services Co. (ATS), a leading provider specializing in aircraft parts and components, as well as offering comprehensive maintenance, repair, and technical services for the...

At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line (1L)...

Mature results from Medivir's phase 1b / 2a open label trial of fostrox + Lenvima® confirm improved outcomes in second-line advanced liver cancer with a median time to progression (TTP) of 10.9...

Organizations worldwide continue to understand the cloud native technology's role in driving innovation across industries VIENNA, Sept. 16, 2024 /PRNewswire/ -- Open Source Summit Europe – The...

TAR-200 plus cetrelimab effective in reducing tumor size in those with muscle-invasive disease, potentially improving surgical outcomes and lowering risk of recurrence BARCELONA, Spain, Sept. 16, 2024

The Men's Health Summit 2024! The Complete Health Guide for Men and Women will be held at the Virginia Beach Oceanfront Hilton on Saturday, October 5, 2024. Topics will include all issues of the...

Today, the ELISA (Enabling Linux in Safety Applications) Project welcomes Hamburg University Technology - Institute of Aircraft Systems Engineering and Lynx Software Technologies to its ecosystem....

ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk BCG-failure non-muscle invasive bladder...

Median duration of response reaches 7.4 months with combination treatment in patients with aggressive form of disease New results show potential of RYBREVANT® beyond lung cancer BARCELONA, Sept....

SmallRig recently showcased three innovative products at the IBC Show 2024 in the Netherlands. These cutting-edge releases are designed to revolutionize the way creators approach lighting and...

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE,...